In tune with the previous reports, our cohort of premenopausal BC had higher proportion of ER negative, HER2 amplified and TNBC tumors compared to postmenopausal tumors which were predominantly hormone receptor positive (9, 28, 2). The gene discussed is ESR1; the disease is breast cancer.